Ebola vaccine: testing in affected regions?

Ebola vaccine: testing in affected regions?

Ebola vaccine will soon be tested in West Africa

Among other things, German researchers are working on the fact that a vaccine against Ebola can soon be tested in the outbreak area in West Africa. More than 8,400 people have already fallen victim to the deadly infectious disease. Experts have now expressed doubts about vaccine studies starting in the coming weeks.

German researchers happy with the results Marburg researchers are also working flat out to ensure that a vaccine against Ebola can soon be tested in the outbreak area of ​​West Africa, reports the news agency dpa. As the virologist Stephan Becker from the University of Marburg announced, it should start in late January or early February. The scientist was satisfied with the first, partly preliminary results of the international study: "I think everyone is happy that there have been no serious side effects."

Side effects were expected. Clinical trials of the vaccine against the deadly virus started in November. 200 to 300 participants will be vaccinated in Hamburg, Switzerland, and in the African countries Gabon and Kenya, which are not affected by the current outbreak. The Marburg researchers will then test their blood samples for antibodies. The aim is to test the safety and effectiveness of the vaccine. According to Becker, side effects such as joint pain occurred in the test subjects, but these were to be expected and also resolved on their own. According to him, preliminary results show that the test subjects responded to the vaccine with an immune response. "However, we naturally do not know whether this immune response can then also protect the test subject from Ebola." This can only be tested in the outbreak area.

Large vaccine studies start According to the World Health Organization (WHO), the Ebola epidemic in West Africa has already fallen victim to over 8,400 people, and over 21,000 people have contracted the disease. So far, only the typical Ebola symptoms can be treated for infected people due to a lack of medicines or approved vaccines. Large vaccine studies in the epidemic areas in West Africa are expected to begin in the next few weeks. But experts have doubts about the success of the planned Ebola vaccination studies, as reported. Scientists and pharmaceutical manufacturers fear that the effectiveness of the vaccines may be difficult to prove. (ad)

Photo credit: CFalk / pixelio.de

Author and source information

Video: October 2019 ACIP Meeting - Ebola Vaccine